7d
Zacks.com on MSNPfizer Sells Remaining 7.3% Stake in Haleon for Around 3.3BPfizer PFE has sold off its remaining stake in consumer health company Haleon HLN to institutional investors and Haleon ...
Bengaluru: Pfizer will divest its remaining stake in Haleon, marking its complete exit from the British consumer healthcare ...
GSK's consumer health spinout Haleon started ... a decade – has annual sales of around £10 billion from brands like Sensodyne toothpaste, Voltaren and Panadol painkillers, and Centrum ...
Sensodyne's brand purpose is to create an oral care future that is sensitivity‐free; we wanted to create a mobile-first digital experience that would help the brand achieve this goal. While the legacy ...
Pfizer still owns about 7.3% of the company making it the largest shareholder. GSK sold its remaining stake in May last year.
In preparation of separating from GSK, its former parent ... Consult studied consumer loyalty associated with brands and found that toothpaste ranked second out of a group of personal-care ...
Pfizer sold its entire 7.3% shareholding in London-listed consumer-health company Haleon for a net sum of 2.5 billion pounds ($3.25 billion). Pfizer sold 618 million shares for 385 pence each. The ...
The business, spun off from drugmaker GSK in 2022, saw operating profit rise 10.5% ... also in line with analysts’ estimates. Haleon’s power brands like Sensodyne toothpaste and Centrum multivitamins ...
encompassing everything from Sensodyne toothpaste to hepatitis vaccines. Dame Emma countered that criticism by spinning off GSK’s consumer brands into a new company, Haleon, in 2022. However ...
Haleon--which owns brands such as Sensodyne toothpaste, Aquafresh mouthwash and over-the-counter medicines Panadol and Advil--was formed in July 2019 through the merger of GSK and Pfizer's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results